Theriva Biologics files $2.5M at-the-market equity offering through A.G.P.

Theriva Biologics, Inc.

Up to $2,534,352 of common stock registered for sale via ATM method with A.G.P./Alliance Global Partners.
Sales agent commission rate set at up to 3.0% of gross proceeds per share sold.
No minimum sale requirement; agent uses commercially reasonable efforts on a principal or agency basis.
Proceeds will be used for general corporate purposes; no escrow or trust arrangement.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.